<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Barbiturates Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects</title>
  <meta name="description" content="Barbiturates Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects — part of Pharmacology Course" />
  <link rel="stylesheet" href="style.css">
</head>
<body>

  <!-- Header -->
  <header class="site-header">
    <div class="container">
      <div class="logo">
        <a href="index.html">Dr M Medical Courses</a>
      </div>
      <nav class="main-nav">
        <ul>
          <li><a href="index.html">Home</a></li>
          <li><a href="orthopedics.html">Orthopedics Courses</a></li>
          <li><a href="pharmacology.html">Pharmacology Courses</a></li>
          <li><a href="about.html">About</a></li>
        </ul>
      </nav>
    </div>
  </header>

  <main>
    <header>
      <h1>Barbiturates Pharmacology: Mechanism of Action, Therapeutic Uses & Adverse Effects</h1>
      <p class="lead">Overview of barbiturates, their mechanism of action, clinical uses, adverse effects, and toxicity management.</p>
    </header>

    <section id="overview">
      <h2>Overview</h2>
      <ul>
        <li>Barbiturates are sedative hypnotic drugs. Other sedative hypnotics include benzodiazepines, Z-drugs, and other hypnotics.</li>
        <li>Barbiturates are dangerous because they may cause respiratory and vasomotor depression.</li>
        <li>Amylobarbitone was the first barbiturate discovered in 1928 and used as an intravenous anesthetic.</li>
        <li>Sedative effect: reduction in CNS activity, leading to reduced anxiety and a calming effect.</li>
        <li>Hypnotic effect: further reduction in CNS activity, leading to drowsiness and sleep.</li>
        <li>Barbiturates can achieve both effects depending on the dose.</li>
      </ul>
    </section>

    <section id="danger">
      <h2>Why Barbiturates Are Dangerous</h2>
      <ul>
        <li>Increasing the dose of barbiturates leads to more CNS depression, which can result in coma, respiratory and vasomotor depression, and death.</li>
        <li>This does not occur with benzodiazepines, making them safer alternatives.</li>
      </ul>
    </section>

    <section id="classification">
      <h2>Barbiturates Classification</h2>
      <table>
        <thead>
          <tr>
            <th>Type</th>
            <th>Examples</th>
            <th>Duration</th>
            <th>T<sub>1/2</sub></th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td>Ultra short acting</td>
            <td>Thiopental, Methohexital</td>
            <td>30 min</td>
            <td>8–10 h</td>
          </tr>
          <tr>
            <td>Short acting</td>
            <td>Hexobarbital, Pentobarbital, Secobarbital</td>
            <td>2 h</td>
            <td>10–40 h</td>
          </tr>
          <tr>
            <td>Intermediate acting</td>
            <td>Amobarbital, Butalbital</td>
            <td>3–6 h</td>
            <td>15–50 h</td>
          </tr>
          <tr>
            <td>Long acting</td>
            <td>Phenobarbital, Primidone</td>
            <td>6 h</td>
            <td>80–120 h</td>
          </tr>
        </tbody>
      </table>
    </section>

    <section id="pharmacokinetics">
      <h2>Pharmacokinetics</h2>
      <ul>
        <li><strong>Absorption:</strong> Oral formulations are rapidly absorbed with good bioavailability (e.g., phenobarbital ~90%).</li>
        <li><strong>Distribution:</strong> Highly lipid soluble, distribute to most body tissues including the brain, then rapidly redistribute to muscle and fat, decreasing plasma and brain concentrations. Redistribution terminates central effects.</li>
        <li><strong>Metabolism:</strong> Mainly in the liver by oxidation.</li>
        <li><strong>Excretion:</strong> Renal.</li>
      </ul>
    </section>

    <section id="mechanism">
      <h2>Mechanism of Action</h2>
      <ul>
        <li>Barbiturates act on GABA<sub>A</sub> receptors in the CNS.</li>
        <li>GABA receptors are pentameric (five subunits) and are the chief inhibitory receptors in the CNS.</li>
        <li>Normally activated by GABA neurotransmitter, leading to opening of chloride channels, reducing neuronal excitability and inhibiting nerve transmission (CNS inhibition).</li>
        <li>Barbiturates enhance GABA action by interacting with alpha and beta subunits of GABA<sub>A</sub> receptors, increasing chloride ion flow, resulting in hyperpolarization and CNS depression.</li>
        <li>Other sedative hypnotics (benzodiazepines, Z-drugs) also increase chloride flow via GABA receptors.</li>
      </ul>
    </section>

    <section id="effects">
      <h2>Pharmacologic Effects</h2>
      <ul>
        <li>Antianxiety effect at small doses.</li>
        <li>Sedative and hypnotic effects at larger doses.</li>
        <li>Anesthetic effect (thiopental, methohexital IV for short periods).</li>
        <li>Euphoria.</li>
        <li>Anticonvulsant effect (phenobarbital for tonic-clonic seizures).</li>
        <li>Generalized CNS inhibition, including medullary centers in toxic doses (hypotension, bradycardia, apnea).</li>
        <li>Induction of hepatic microsomal enzymes.</li>
      </ul>
    </section>

    <section id="uses">
      <h2>Therapeutic Uses</h2>
      <ul>
        <li>Phenobarbital: treatment of tonic-clonic seizures.</li>
        <li>Phenobarbital: hepatic enzyme inducer for physiological jaundice in neonates.</li>
        <li>Thiopental: induction of anesthesia (now replaced by propofol).</li>
        <li>Thiopental: used for interrogation (requires more CNS activity to lie).</li>
        <li>Methohexital: procedural anesthesia for cardioversion and fracture reduction.</li>
        <li>Barbiturates were used for neonatal withdrawal, insomnia, and anxiety (now mostly replaced by benzodiazepines and newer hypnotics).</li>
      </ul>
    </section>

    <section id="adverse">
      <h2>Adverse Effects</h2>
      <ul>
        <li>Tolerance and physical dependence (decreased GABA sensitivity, increased excitatory transmitters such as NMDA receptors).</li>
        <li>Drowsiness and impaired concentration.</li>
        <li>Hangover: psychomotor depression the day after use of long-acting drugs.</li>
        <li>Respiratory and myocardial depression (especially IV forms).</li>
        <li>Increased porphyrin synthesis (may precipitate acute intermittent porphyria).</li>
        <li>Extravasation of thiopental can cause severe tissue necrosis (treated with local anesthetic and lidocaine injection).</li>
        <li>Hepatotoxicity (especially with phenobarbital).</li>
      </ul>
    </section>

    <section id="interactions">
      <h2>Drug Interactions</h2>
      <ul>
        <li>Phenobarbital is a strong CYP inducer: lowers plasma levels of other antiepileptics (lamotrigine, phenytoin, valproate), causes contraceptive failure, and affects other CYP-metabolized drugs.</li>
      </ul>
    </section>

    <section id="contraindications">
      <h2>Contraindications</h2>
      <ul>
        <li>Severe respiratory insufficiency.</li>
        <li>Sleep apnea syndrome.</li>
        <li>Acute narrow angle glaucoma (increases IOP).</li>
        <li>Pregnancy (teratogenic).</li>
        <li>Use with other CNS depressants (e.g., alcohol).</li>
      </ul>
    </section>

    <section id="toxicity">
      <h2>Toxicity</h2>
      <ul>
        <li>Barbiturates can be abused; overdose may occur intentionally or due to hepatic/renal problems.</li>
        <li>Acute toxicity: CNS depression, respiratory failure, hemodynamic instability.</li>
      </ul>
    </section>

    <section id="treatment">
      <h2>Treatment of Toxicity</h2>
      <ul>
        <li>No antidote available.</li>
        <li>Mechanical ventilation.</li>
        <li>IV fluids.</li>
        <li>Alkalinization of urine (barbiturates are acidic drugs).</li>
      </ul>
    </section>

    <section id="course-menu">
      <h2>Course Menu</h2>
      <p>This article is part of the Pharmacology Course. Other topics include:</p>
      <ul class="course-list">
        <li>Pharmacology Basic Principles</li>
        <li>CNS Pharmacology</li>
        <li>Antibiotic Pharmacology</li>
        <li>Diuretics Pharmacology</li>
        <li class="active">Barbiturates Pharmacology</li>
      </ul>
    </section>
  </main>

  <footer>
    <p>&copy; 2025 Dr M. All Rights Reserved.</p>
  </footer>

</body>
</html>